New combo therapy and advanced scans aim to improve prostate cancer detection and treatment

This study tested a combination of three hormone-blocking drugs (enzalutamide, abiraterone, and standard hormone therapy) given before surgery in 12 men with newly diagnosed prostate cancer that hasn't spread. Researchers also used special PET/CT scans with a new tracer to see if they could better detect and track the cancer. The goal was to improve treatment and imaging, but men still needed surgery and long-term follow-up, so this is about controlling the disease, not curing it.